AIGH Capital Management LLC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGH Capital Management LLC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$10,255,419
-31.6%
4,619,558
+4.7%
4.85%
-20.7%
Q2 2023$15,002,816
+4.2%
4,412,593
+22.3%
6.12%
+15.3%
Q1 2023$14,401,291
-26.7%
3,609,3460.0%5.31%
-17.9%
Q4 2022$19,634,842
+3.5%
3,609,346
-4.3%
6.47%
+9.7%
Q3 2022$18,978,000
+34.9%
3,772,875
-0.2%
5.90%
+59.4%
Q2 2022$14,063,0003,778,9373.70%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
View complete list of TRANSPHORM INC shareholders